2022
DOI: 10.21608/svu.2022.133515.1192
|View full text |Cite
|
Sign up to set email alerts
|

Molecular mechanism of Copper Albumin Complex on NDEA induced brain vascular damage via promoting VEGF expression.

Abstract: Nitrosodiethylamine (NDEA) is a potent oxidant induces neurodegeneration via (reactive oxygen species) ROS. Copper is an important metal essential for scavenging free radicals, development of central nervous system (CNS) and redox angiogenesis signaling. Vascular endothelial growth factor (VEGF) is well known as efficacious and long-term signal that stimulates angiogenesis, where its expression is copper dependent. We examined the copper protective effect against brain vascular damage initiated by NDEA. NDEA i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Positive control: included on 20 osteoarthritic rats which left without treatment and were divided equally into mild and severe not treated subgroups according to the detected clinical signs which are pain, swelling and, lameness. Treated group: included on 20 osteoarthritic rats which were divided equally into mild and severe treated groups according to severity of clinical signs and treated orally with copper albumin complex (obtained from Prof. Dr. Ahmed Yassein Nassar, professor of biochemistry, faculty of Medicine, Assiut University, Assiut, Egypt as patent cooperation treaty (PCT) in the international Bureau of World Intellectual Property Organization (WIPO), Geneva, Switzerland / World Organization (WO) 2008 / 028497) for a month at a dose of 1 ml/kg B.W daily after suspension of 817μg/kg copper albumin complex in water (Taha et al, 2022).…”
Section: Experimental Groupsmentioning
confidence: 99%
“…Positive control: included on 20 osteoarthritic rats which left without treatment and were divided equally into mild and severe not treated subgroups according to the detected clinical signs which are pain, swelling and, lameness. Treated group: included on 20 osteoarthritic rats which were divided equally into mild and severe treated groups according to severity of clinical signs and treated orally with copper albumin complex (obtained from Prof. Dr. Ahmed Yassein Nassar, professor of biochemistry, faculty of Medicine, Assiut University, Assiut, Egypt as patent cooperation treaty (PCT) in the international Bureau of World Intellectual Property Organization (WIPO), Geneva, Switzerland / World Organization (WO) 2008 / 028497) for a month at a dose of 1 ml/kg B.W daily after suspension of 817μg/kg copper albumin complex in water (Taha et al, 2022).…”
Section: Experimental Groupsmentioning
confidence: 99%
“…C-Twenty treated rats' group, where the rats were divided into mild and severe treated groups (10 rats each) based on the severity of their symptoms. After dissolving 817μg/kg of copper albumin complex in water, the rats were given copper albumin complex orally once daily for a month at a dose of 1 ml/kg B.W (Taha et al, 2022).…”
Section: Experimental Groupsmentioning
confidence: 99%